ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Vulvar and vaginal graft versus host disease in a patient with chronic phase chronic myeloid leukemia after allogeneic stem cell transplantation
Abstract
Graft versus Host Disease (GVHD) is one of the serious complications of allogeneic stem cell transplantation in the treatment of many hematological malignancies. Skin, liver, and eyes are frequently affected areas. In addition to frequently affected areas, genital region involvement can also be seen. Allogeneic stem cell transplantation is one of the definitive treatments for hematological malignancies seen in the young age group. And its use for therapeutic purposes in young patients is increasing daily. Vulvovaginal GVHD is a disease type that concerns female patients of reproductive age. In this case report, we wanted to report in the literature a case that underwent allogeneic stem cell transplantation after CML diagnosis and TKI resistance and then developed vulvovaginal GVHD. In vaginal disease involvement; in addition to many genitourinary complaints, many negativities in sexual life and deterioration in quality of life are experienced. The chronic GVHD patient we treated is currently continuing her treatment response follow-ups. Our aim in presenting this case to the literature is to emphasize that GVHD should be included in the differential diagnosis in female patients with hematological disease and vaginal involvement.

Keywords : GVHD, chronic myeloid leukemia, allogeneic stem cell transplantation

Download Article


1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561. doi:10.1016/S0140-6736(09)60237-3
2. Vaidya T, Menzer C, Ponce DM, Markova A. Inpatient management of mucocutaneous GVHD. Curr Dermatol Rep. 2019;8(4):258-278. doi:10. 1007/s13671-019-00280-3
3. Beres AJ, Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol. 2013;4:163. doi:10.3389/fimmu. 2013.00163
4. Smith Knutsson E, Nicklasson M, Björk Y, Stenberg K, Sundfeldt K, Brune M. Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation. Acta Obstet Gynecol Scand. 2022;101(3):364-373. doi: 10.1111/aogs.14308
5. Corson SL, Sullivan K, Batzer F, August C, Storb R, Thomas ED. Gynecologic manifestations of chronic graft-versus-host disease. Obstet Gynecol. 1982;60(4):488-492. doi.org/10.1017/CBO9780511576751.020
6. Spinelli S, Chiodi S, Costantini S, et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica. 2003;88(10):1163-1168.
7. Machado AMN, Hamerschlak N, Rodrigues M, Piccinato CA, Podgaec S, Mauad LMQ. Female genital tract chronic graft-versus-host disease: a narrative review. Hematol Transfus Cell Ther. 2019;41(1):69-75. doi:10. 1016/j.htct.2018.06.005
8. Stratton P, Turner ML, Childs R, et al. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol. 2007;110(5):1041-1049. doi:10.1097/01.AOG.0000285998.75450.86
9. Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant. 2006;38(8):567-572. doi:10.1038/sj.bmt.1705487
10. Flowers ME, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100(2):415-419. doi:10.1182/blood-2002- 01-0011
11. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease V. Biol Blood Marrow Transplant. 2006;12(4):375-396. doi:10.1016/j.bbmt.2006.02.003
12. Cizek SM, El-Bietar J, Rubinstein J, et al. Pediatric and young adult vulvovaginal graft-versus-host disease. Biol Blood Marrow Transplant. 2019;25(12):2408-2415. doi:10.1016/j.bbmt.2019.07.015
13. Kornik RI, Rustagi AS. Vulvovaginal graft-versus-host disease. Obstet Gynecol Clin North Am. 2017;44(3):475-492. doi:10.1016/j.ogc.2017.05. 007
14. Hirsch P, Leclerc M, Rybojad M, et al. Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications. Transplantation. 2012;93(12):1265-1269. doi:10.1097/TP. 0b013e31824f3dcd
15. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.Biol Blood Marrow Transplant. 2003;9(12):760-765. doi:10.1016/j.bbmt.2003.08.001
Article available in :
Volume 3, Issue 1, 2025
Page : 19-21
https://doi.org/10.51271/ICJIM-0051
Article Information
Received : 06 Ara 2024
Accepted : 12 Oca 2025
Published : 07 Şub 2025
Corresponding Author :

Mehmet Orhan Ayyıldız: Department of Hematology, Faculty of Medicine, Dicle University, Diyarbakır, Turkiye

[email protected]
Citation : Ayyıldız O, Karakuş A, Pirinçci E, Gündüz R. Vulvar and vaginal graft versus host disease in a patient with chronic phase chronic myeloid leukemia after allogeneic stem cell transplantation. Intercont J Int Med. 2025;3(1):19-21.

Read: 61
Cited: 0
Download : 104
_Footer